Ann Dermatol.
2016 Jun;28(3):381-382. 10.5021/ad.2016.28.3.381.
Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema
- Affiliations
-
- 1Department of Allergy and Immunology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
- 2Department of Dermatology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
- 3Department of Dermatology, Kasimpasa Military Hospital, Istanbul, Turkey. drersinaydin@yahoo.com
- 4Department of Physical Medicine and Rehabilitation, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
- KMID: 2164648
- DOI: http://doi.org/10.5021/ad.2016.28.3.381
Abstract
- No abstract available.
Reference
-
1. Metz M, Maurer M. Omalizumab in chronic urticaria. Curr Opin Allergy Clin Immunol. 2012; 12:406–411.
Article2. Song CH, Stern S, Giruparajah M, Berlin N, Sussman GL. Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria. Ann Allergy Asthma Immunol. 2013; 110:113–117.
Article3. von Websky A, Reich K, Steinkraus V, Breuer K. Complete remission of severe chronic recurrent angioedema of unknown cause with omalizumab. J Dtsch Dermatol Ges. 2013; 11:677–678.
Article4. Sayama K, Diehn M, Matsuda K, Lunderius C, Tsai M, Tam SY, et al. Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11. BMC Immunol. 2002; 3:5.5. Noga O, Hanf G, Brachmann I, Klucken AC, Kleine-Tebbe J, Rosseau S, et al. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma. J Allergy Clin Immunol. 2006; 117:1493–1499.
Article
